等待開盤 03-26 09:30:00 美东时间
+1.510
+3.49%
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
Mizuho analyst Ann Hynes maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $50 to $52.
03-18 20:27
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
BrightSpring Health Services, Inc. (NASDAQ: BTSG) ("BrightSpring" or the "Company"), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the "Selling Stockholders"), including an affiliate of Kohlberg Kravis Roberts & Co. L.P.
03-03 05:37
BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $55 price target.
03-02 18:19
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gainers include AAOI, NGNE, ARLO, PRAA, BYND, BWIN, PSKY, & DELL.
02-28 01:52
华盛资讯2月27日讯,BrightSpring Health Services, Inc.公布2025财年年度业绩,公司年度营收129.11亿美元,同比增长28.2%,归母净利润1.06亿美元,扭亏为盈。
02-27 22:00
华盛资讯2月27日讯,BrightSpring Health Services, Inc.公布2025财年Q4业绩,公司Q4营收35.51亿美元,同比增长29.3%,归母净利润0.77亿美元,同比增长381.3%。
02-27 20:21